India Urged By GE Asia Head To Treat Material Imports Same As Products
This article was originally published in PharmAsia News
India needs to stop discriminating with its customs laws between finished products and components if Indian device makers and others are to produce more, the South Asia head of GE Healthcare says
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.